Genvor Incorporated Narrows Q1 Loss to $576K as Operating Expenses Plunge 89%
The Nevada-based company reported a net loss of $576,280 for the quarter ending December 31, down sharply from a $5.0 million loss a year earlier. Operating expenses fell to $562,655 from nearly $5.0 million.
Genvor Incorporated, a Nevada-incorporated small business filer, posted a net loss of $576,280 for the three months ending December 31, 2025, a dramatic improvement from the $5.0 million loss recorded in the same quarter of fiscal 2025. The company reported no revenue for the period. Read more earnings reports.
Operating expenses declined 89% to $562,655 from $4.99 million in the prior-year quarter, driving the narrower loss. Research and development spending fell to $57,147 from $63,424, while interest expense rose to $15,025 from $3,837.
Cash used in operations totaled $193,651 for the quarter, up substantially from $1,442 a year earlier. The company raised $260,000 from financing activities during the period, compared to just $1,650 in the prior-year quarter.
Genvor ended the quarter with $103,580 in cash, up from $37,231 at the end of the prior fiscal quarter and $581 at December 31, 2024. Total assets rose to $145,739 from $45,822 at the end of the prior quarter.
The company remained in a negative equity position, with stockholders' deficit of $1.06 million at quarter-end versus a deficit of $1.31 million at September 30, 2025. Total liabilities decreased to $1.21 million from $1.36 million in the prior quarter. Retained deficit stood at $26.8 million.
Common shares outstanding increased to 34.4 million at December 31 from 30.2 million at the end of the prior quarter. The company reported a loss per share of $0.02 on both a basic and diluted basis, compared to a loss of $0.24 per share in the year-earlier quarter.
Financial Summary
| Metric | Q1 FY2026 | Q1 FY2025 | Change |
|---|---|---|---|
| Net Loss | ($576,280) | ($5,001,251) | -88% |
| Operating Expenses | $562,655 | $4,997,414 | -89% |
| R&D Expenses | $57,147 | $63,424 | -10% |
| Cash from Operations | ($193,651) | ($1,442) | — |
| Cash from Financing | $260,000 | $1,650 | — |
| EPS (Basic & Diluted) | ($0.02) | ($0.24) | -92% |
Balance Sheet Highlights
| Item | Dec 31, 2025 | Sep 30, 2025 |
|---|---|---|
| Cash & Restricted Cash | $103,580 | $37,231 |
| Total Assets | $145,739 | $45,822 |
| Total Liabilities | $1,205,059 | $1,358,204 |
| Stockholders' Deficit | ($1,059,320) | ($1,312,382) |
| Shares Outstanding | 34,430,605 | 30,175,763 |